Open Access

Differential proteomic screening and identification for non-traumatic necrotic femoral osseous tissue

  • Authors:
    • Peng Yan
    • Yeping Zhu
    • Hui Zhao
    • Yanyan Lu
    • Yuzhong Gao
  • View Affiliations

  • Published online on: April 12, 2017     https://doi.org/10.3892/etm.2017.4326
  • Pages: 2900-2904
  • Copyright: © Yan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Currently, there is a lack of effective early screening and detection methods for femoral head necrosis. Current research on most orthopedic diseases focuses on proteomics in the preliminary stage. The recent fluorescence differential in gel electrophoresis (DIGE) has advantages such as a high reproducibility, high sensitivity, high throughput, and high dynamic range. It is currently one of the most widely used quantitative proteomic research means. We conducted this study to investigate the pathogenesis of non-traumatic femoral head necrosis using the fluorescence DIGE to screen non-traumatic femoral head necrosis based on proteomics and provide a theoretical basis for screening possible biomarkers and molecular targeted treatment. The DIGE technique was used to separate the protein. An electrophoretogram was established on the basis of scanning and analysis. Identification and a bioinformatics analysis were conducted for the differential protein. The protein with differential expression of over 2-fold was excavated and ionized by means of substrate assisted laser desorption. The flight time was identified with a mass spectrometer (matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, MALDI-TOF/TOF). The formation on sequences, structures and functions of these proteins were obtained through database retrieval. Western blot analysis was used to verify the differential protein expression and the reliability of the DIGE result was verified. DIGE was used to successfully separate 1,500±40 protein spots. There were 252 significant differential protein spots. The Ettan™ Spot Picker automatic work station was used to excavate 49 significant differential protein spots with expression difference over 2-fold. The MALDI-TOF/TOF mass spectrometer was used to identify these differential protein spots. Six proteins were identified in total, which include apolipoprotein A1 (APOA1), fibrous protein original chain, fibrous protein original chain, serum albumin, sulfur-oxygen protein peroxiredoxin 2 (PRDX2) and actin. APOA1 and PRDX2 were subject to western blot analysis detection; results were consistent with the DIGE result. Based on an analysis of the biological information, these proteins may be associated with the incidence and progression of femoral head necrosis.

Related Articles

Journal Cover

June-2017
Volume 13 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yan P, Zhu Y, Zhao H, Lu Y and Gao Y: Differential proteomic screening and identification for non-traumatic necrotic femoral osseous tissue. Exp Ther Med 13: 2900-2904, 2017
APA
Yan, P., Zhu, Y., Zhao, H., Lu, Y., & Gao, Y. (2017). Differential proteomic screening and identification for non-traumatic necrotic femoral osseous tissue. Experimental and Therapeutic Medicine, 13, 2900-2904. https://doi.org/10.3892/etm.2017.4326
MLA
Yan, P., Zhu, Y., Zhao, H., Lu, Y., Gao, Y."Differential proteomic screening and identification for non-traumatic necrotic femoral osseous tissue". Experimental and Therapeutic Medicine 13.6 (2017): 2900-2904.
Chicago
Yan, P., Zhu, Y., Zhao, H., Lu, Y., Gao, Y."Differential proteomic screening and identification for non-traumatic necrotic femoral osseous tissue". Experimental and Therapeutic Medicine 13, no. 6 (2017): 2900-2904. https://doi.org/10.3892/etm.2017.4326